Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
OtherBASIC SCIENCE INVESTIGATIONS

Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes

Michael R. McDevitt, Debjit Chattopadhyay, Barry J. Kappel, Jaspreet Singh Jaggi, Scott R. Schiffman, Christophe Antczak, Jon T. Njardarson, Renier Brentjens and David A. Scheinberg
Journal of Nuclear Medicine July 2007, 48 (7) 1180-1189; DOI: https://doi.org/10.2967/jnumed.106.039131
Michael R. McDevitt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debjit Chattopadhyay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry J. Kappel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaspreet Singh Jaggi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott R. Schiffman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Antczak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon T. Njardarson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renier Brentjens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Scheinberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Abstract

Single-walled carbon nanotubes (CNT) are mechanically robust graphene cylinders with a high aspect ratio that are comprised of sp2-bonded carbon atoms and possessing highly regular structures with defined periodicity. CNT exhibit unique mechanochemical properties that can be exploited for the development of novel drug delivery platforms. We hypothesized that novel prototype nanostructures consisting of biologics, radionuclides, fluorochromes, and CNT could be synthesized and designed to target tumor cells. Methods: Tumor-targeting CNT constructs were synthesized from sidewall-functionalized, water-soluble CNT platforms by covalently attaching multiple copies of tumor-specific monoclonal antibodies, radiometal-ion chelates, and fluorescent probes. The constructs were characterized spectroscopically, chromatographically, and electrophoretically. The specific reactivity of these constructs was evaluated in vitro by flow cytometry and cell-based immunoreactivity assays and in vivo using biodistribution in a murine xenograft model of lymphoma. Results: A soluble, reactive CNT platform was used as the starting point to build multifunctional constructs with appended antibody, metal-ion chelate, and fluorescent chromophore moieties to effect specific targeting, to carry and deliver a radiometal-ion, and to report location, respectively. These nanoconstructs were found to be specifically reactive with the human cancer cells they were designed to target in vivo in a model of disseminated human lymphoma and in vitro by flow cytometry and cell-based immunoreactivity assays versus appropriate controls. Conclusion: The key achievement in these studies was the selective targeting of tumor in vitro and in vivo by the use of specific antibodies appended to a soluble, nanoscale CNT construct. The ability to specifically target tumor with prototype-radiolabeled or fluorescent-labeled, antibody-appended CNT constructs was encouraging and suggested further investigation of CNT as a novel delivery platform.

  • single-walled carbon nanotubes
  • Rituximab
  • DOTA
  • nanoconstructs
  • nanotechnology

Footnotes

  • ↵* Contributed equally to this work.

  • COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (7)
Journal of Nuclear Medicine
Vol. 48, Issue 7
July 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes
Michael R. McDevitt, Debjit Chattopadhyay, Barry J. Kappel, Jaspreet Singh Jaggi, Scott R. Schiffman, Christophe Antczak, Jon T. Njardarson, Renier Brentjens, David A. Scheinberg
Journal of Nuclear Medicine Jul 2007, 48 (7) 1180-1189; DOI: 10.2967/jnumed.106.039131

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes
Michael R. McDevitt, Debjit Chattopadhyay, Barry J. Kappel, Jaspreet Singh Jaggi, Scott R. Schiffman, Christophe Antczak, Jon T. Njardarson, Renier Brentjens, David A. Scheinberg
Journal of Nuclear Medicine Jul 2007, 48 (7) 1180-1189; DOI: 10.2967/jnumed.106.039131
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury
  • Encapsulation of {alpha}-Particle-Emitting 225Ac3+ Ions Within Carbon Nanotubes
  • Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
  • Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
  • Paradoxical glomerular filtration of carbon nanotubes
  • Cancer Nanotargeted Radiopharmaceuticals for Tumor Imaging and Therapy
  • Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation
  • Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
  • Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes
  • Multimodality Molecular Imaging of Tumor Angiogenesis
  • Noninvasive molecular imaging of small living subjects using Raman spectroscopy
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire